FAYENCE SARREGUEMINES DIGOIN (FAYE.PA) Fundamental Analysis & Valuation

EPA:FAYE • FR0000031973

16.9 EUR
-0.9 (-5.06%)
Last: Jun 26, 2025, 07:00 PM

This FAYE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FAYE. FAYE was compared to 32 industry peers in the Household Durables industry. FAYE has a great financial health rating, but its profitability evaluates not so good. FAYE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. FAYE.PA Profitability Analysis

1.1 Basic Checks

  • FAYE had negative earnings in the past year.
  • In the past year FAYE has reported a negative cash flow from operations.
  • In the past 5 years FAYE always reported negative net income.
  • In the past 5 years FAYE always reported negative operating cash flow.
FAYE.PA Yearly Net Income VS EBIT VS OCF VS FCFFAYE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K

1.2 Ratios

  • The Return On Assets of FAYE (-46.45%) is worse than 96.67% of its industry peers.
  • FAYE's Return On Equity of -64.64% is on the low side compared to the rest of the industry. FAYE is outperformed by 90.00% of its industry peers.
Industry RankSector Rank
ROA -46.45%
ROE -64.64%
ROIC N/A
ROA(3y)-28.15%
ROA(5y)-22.52%
ROE(3y)-33.09%
ROE(5y)-25.83%
ROIC(3y)N/A
ROIC(5y)N/A
FAYE.PA Yearly ROA, ROE, ROICFAYE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FAYE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FAYE.PA Yearly Profit, Operating, Gross MarginsFAYE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

9

2. FAYE.PA Health Analysis

2.1 Basic Checks

  • FAYE has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for FAYE remains at a similar level compared to 5 years ago.
  • FAYE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FAYE.PA Yearly Shares OutstandingFAYE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
FAYE.PA Yearly Total Debt VS Total AssetsFAYE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • FAYE has an Altman-Z score of 3.84. This indicates that FAYE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.84, FAYE belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • FAYE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.84
ROIC/WACCN/A
WACCN/A
FAYE.PA Yearly LT Debt VS Equity VS FCFFAYE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

  • A Current Ratio of 4.10 indicates that FAYE has no problem at all paying its short term obligations.
  • FAYE has a better Current ratio (4.10) than 86.67% of its industry peers.
  • A Quick Ratio of 4.10 indicates that FAYE has no problem at all paying its short term obligations.
  • The Quick ratio of FAYE (4.10) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 4.1
FAYE.PA Yearly Current Assets VS Current LiabilitesFAYE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

0

3. FAYE.PA Growth Analysis

3.1 Past

  • FAYE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.18%.
EPS 1Y (TTM)-35.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. FAYE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • FAYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FAYE.PA Price Earnings VS Forward Price EarningsFAYE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FAYE.PA Per share dataFAYE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. FAYE.PA Dividend Analysis

5.1 Amount

  • FAYE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FAYE.PA Fundamentals: All Metrics, Ratios and Statistics

FAYENCE SARREGUEMINES DIGOIN

EPA:FAYE (6/26/2025, 7:00:00 PM)

16.9

-0.9 (-5.06%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.54M
Revenue(TTM)N/A
Net Income(TTM)-660.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.48
P/tB 2.5
EV/EBITDA N/A
EPS(TTM)-5.79
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-2.83
OCFYN/A
SpS0
BVpS6.81
TBVpS6.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.45%
ROE -64.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-28.15%
ROA(5y)-22.52%
ROE(3y)-33.09%
ROE(5y)-25.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 4.1
Altman-Z 3.84
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.82%
OCF growth 3YN/A
OCF growth 5YN/A

FAYENCE SARREGUEMINES DIGOIN / FAYE.PA FAQ

What is the fundamental rating for FAYE stock?

ChartMill assigns a fundamental rating of 3 / 10 to FAYE.PA.


Can you provide the valuation status for FAYENCE SARREGUEMINES DIGOIN?

ChartMill assigns a valuation rating of 0 / 10 to FAYENCE SARREGUEMINES DIGOIN (FAYE.PA). This can be considered as Overvalued.


What is the profitability of FAYE stock?

FAYENCE SARREGUEMINES DIGOIN (FAYE.PA) has a profitability rating of 0 / 10.


What is the financial health of FAYENCE SARREGUEMINES DIGOIN (FAYE.PA) stock?

The financial health rating of FAYENCE SARREGUEMINES DIGOIN (FAYE.PA) is 9 / 10.